Dong X - Search Results

1

CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.

Dong X, Chen G, Cai Z, Li Z, Qiu L, Xu H, Yuan Y, Liu XL, Liu J. Dong X, et al. Cell Physiol Biochem. 2018;47(6):2602-2612. doi: 10.1159/000491656. Epub 2018 Jul 11. Cell Physiol Biochem. 2018. PMID: 29996118 Free article.

2

Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma.

Cai ZX, Chen G, Zeng YY, Dong XQ, Lin MJ, Huang XH, Zhang D, Liu XL, Liu JF. Cai ZX, et al. Int J Cancer. 2017 Sep 1;141(5):977-985. doi: 10.1002/ijc.30798. Epub 2017 Jun 7. Int J Cancer. 2017. PMID: 28543104

3

Clonal evolution in long-term follow-up patients with hepatocellular carcinoma.

Chen G, Cai Z, Li Z, Dong X, Xu H, Lin J, Chen L, Zhang H, Liu X, Liu J. Chen G, et al. Among authors: dong x. Int J Cancer. 2018 Dec 1;143(11):2862-2870. doi: 10.1002/ijc.31844. Epub 2018 Oct 3. Int J Cancer. 2018. PMID: 30183077

4

Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.

Qiu L, Huang Y, Li Z, Dong X, Chen G, Xu H, Zeng Y, Cai Z, Liu X, Liu J. Qiu L, et al. Among authors: dong x. Mol Oncol. 2019 Feb;13(2):441-455. doi: 10.1002/1878-0261.12424. Epub 2019 Jan 9. Mol Oncol. 2019. PMID: 30537115 Free PMC article.

5

Genomic and transcriptional Profiling of tumor infiltrated CD8⁺ T cells revealed functional heterogeneity of antitumor immunity in hepatocellular carcinoma.

Li Z, Chen G, Cai Z, Dong X, Qiu L, Xu H, Zeng Y, Liu X, Liu J. Li Z, et al. Among authors: dong x. Oncoimmunology. 2018 Nov 10;8(2):e1538436. doi: 10.1080/2162402X.2018.1538436. eCollection 2019. Oncoimmunology. 2018. PMID: 30713796 Free PMC article.

6

ANXA2^Tyr23 and FLNA^Ser2152 phosphorylation associate with poor prognosis in hepatic carcinoma revealed by quantitative phosphoproteomics analysis.

Xing X, Yuan H, Sun Y, Ke K, Dong X, Chen H, Liu X, Zhao B, Huang A. Xing X, et al. Among authors: dong x. J Proteomics. 2019 May 30;200:111-122. doi: 10.1016/j.jprot.2019.03.017. Epub 2019 Apr 2. J Proteomics. 2019. PMID: 30951906

7

Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma.

Cai Z, Chen G, Zeng Y, Dong X, Li Z, Huang Y, Xin F, Qiu L, Xu H, Zhang W, Su X, Liu X, Liu J. Cai Z, et al. Among authors: dong x. Clin Cancer Res. 2019 Sep 1;25(17):5284-5294. doi: 10.1158/1078-0432.CCR-18-3477. Epub 2019 Jun 19. Clin Cancer Res. 2019. PMID: 31217202

8

Dataset for quantitative phospho-proteomics analysis of a serial hepatoma cell lines with increasing invasion and metastasis potential.

Xing X, Yuan H, Sun Y, Ke K, Dong X, Chen H, Liu X, Zhao B, Huang A. Xing X, et al. Among authors: dong x. Data Brief. 2019 Oct 14;27:104634. doi: 10.1016/j.dib.2019.104634. eCollection 2019 Dec. Data Brief. 2019. PMID: 31709285 Free PMC article.

9

Overexpression of galectin-4 promotes cell growth of hepatocellular carcinoma cells in vitro and in vivo.

Chen C, Wang G, Huang X, Dong X, Chen G, Lin M, Cai Z, Zeng Y. Chen C, et al. Among authors: dong x. Int J Clin Exp Pathol. 2017 Oct 1;10(10):10233-10242. eCollection 2017. Int J Clin Exp Pathol. 2017. PMID: 31966357 Free PMC article.

10

Genomic and Transcriptomic Landscape of Tumor Clonal Evolution in Cholangiocarcinoma.

Chen G, Cai Z, Dong X, Zhao J, Lin S, Hu X, Liu FE, Liu X, Zhang H. Chen G, et al. Among authors: dong x. Front Genet. 2020 Mar 13;11:195. doi: 10.3389/fgene.2020.00195. eCollection 2020. Front Genet. 2020. PMID: 32231683 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,041 results

Search Page

Filters